Scott A Fisher

5PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 20, 2021
The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3.

Elly Marcq, Jonas R M Van Audenaerde, Jorrit De Waele

|Sep 16, 2020
Voluntary exercise in mesothelioma: effects on tumour growth and treatment response in a murine model.

Scott A Fisher, Carolyn J Peddle-McIntyre, Kimberley Burton

|Oct 12, 2019
Neo-antigen specific T cell responses indicate the presence of metastases before imaging.

V S Fear, C A Forbes, J Chee

|Oct 06, 2018
Combination immune checkpoint blockade as an effective therapy for mesothelioma.

Vanessa S Fear, Caitlin Tilsed, Jonathan Chee

|Apr 22, 2016
Immunotherapy for lung cancer.

Antonius Steven, Scott A Fisher, Bruce W Robinson

Pageof 1